TransMedics Group, Inc. (TMDX) Operating Margin
- Operating margin · 12 months: Value 12.21%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 12.21% | Operating income / revenue. Period ending 2026-06-30. $81.61M ÷ $668.47M × 100 ≈ 12.21% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 81.61M USD | Operating Income (Loss) |
| Revenue | 668.47M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | |
| Research and development | 92.47M USD | Research and Development Expense |
| Selling, general and administration | 218.27M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $81.61M | $668.47M | (m) | $92.47M | $218.27M | 12.21% |
| 2026-03-31 | $94.44M | $635.89M | (m) | $76.77M | $204.53M | 14.85% |
| 2025-12-31 | $108.58M | $605.49M | (m) | $69.06M | $185.17M | 17.93% |
| 2025-09-30 | $95.95M | $566.35M | (m) | $64.82M | $180.63M | 16.94% |
| 2025-06-30 | $76.58M | $531.29M | (m) | $63.82M | $177.27M | 14.41% |
| 2025-03-31 | $52.52M | $488.23M | (m) | $61.75M | $176.08M | 10.76% |
| 2024-12-31 | $37.50M | $441.54M | (m) | $55.97M | $168.62M | 8.49% |
| 2024-09-30 | $31.45M | $401.09M | (m) | $50.27M | $156.27M | 7.84% |
| 2024-06-30 | $-803.00K | $358.76M | (m) | $47.13M | $144.27M | -0.22% |
| 2024-03-31 | $-14.22M | $296.92M | (m) | $41.56M | $130.73M | -4.79% |
| 2023-12-31 | $-28.73M | $241.62M | (m) | $36.05M | $119.55M | -11.89% |
| 2023-09-30 | $-38.11M | $193.20M | (m) | $31.05M | $106.72M | -19.72% |
| 2023-06-30 | $-15.32M | $151.08M | (m) | $26.73M | $92.92M | -10.14% |
| 2023-03-31 | $-24.16M | $119.13M | (m) | $25.15M | $80.94M | -20.28% |
| 2022-12-31 | $-31.44M | $93.46M | (m) | $26.81M | $69.90M | -33.64% |
| 2022-09-30 | $-35.99M | $70.37M | (m) | $27.37M | $60.17M | -51.14% |
| 2022-06-30 | $-42.17M | $51.48M | (m) | $25.73M | $53.66M | -81.91% |
| 2022-03-31 | $-42.29M | $39.63M | (m) | $25.31M | $45.44M | -106.72% |
| 2021-12-31 | $-39.43M | $31.39M | (m) | $22.30M | $38.28M | -125.63% |
| 2021-09-30 | $-34.00M | $29.34M | (m) | (m) | (m) | -115.85% |
| 2021-06-30 | $-26.88M | $31.90M | (m) | $19.53M | $27.62M | -84.26% |
| 2021-03-31 | $-24.87M | $27.16M | (m) | (m) | (m) | -91.58% |
| 2020-12-31 | $-26.38M | (m) | (m) | $18.83M | $24.19M | (m) |
| 2020-09-30 | $-29.18M | $26.60M | (m) | $20.55M | $24.18M | -109.70% |
| 2020-06-30 | $-31.81M | $26.50M | (m) | $21.33M | $25.21M | -120.03% |
| 2020-03-31 | $-31.66M | $28.80M | (m) | $22.21M | $25.59M | -109.94% |
| 2019-12-28 | $-29.60M | $25.84M | (m) | $19.87M | $23.60M | -114.54% |
| 2019-09-28 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-29 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-03-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-29 | $-20.24M | $14.66M | (m) | $13.66M | $12.31M | -138.07% |
| 2018-09-29 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |